Lipids, risk factors and ischaemic heart disease
- PMID: 8831910
- DOI: 10.1016/0021-9150(96)05851-0
Lipids, risk factors and ischaemic heart disease
Abstract
Over 200 risk factors for cardiovascular disease (CVD) have now been identified. Among these, the three most important are (1) abnormal lipids, including the fact that there are more than 15 types of cholesterol-containing lipoproteins and four different types of triglyceride-rich particles, some of which are very atherogenic, (2) high blood pressure, and (3) cigarette smoking. In addition, many other factors including diabetes, haemostatic factors such as fibrinogen, factor VII, plasminogen activator inhibitors, and new factors such as apolipoprotein E4 and homocysteine, are known to increase the risk of developing clinical CVD. A low risk for CVD requires that these various factors are present in the circulation in the correct proportions. Two simple tests for determining plasma lipid levels can be used to identify those individuals with an atherogenic lipid profile and who are, therefore, at increased risk for CVD. Firstly, the ratio of total cholesterol to high density cholesterol (HDL cholesterol) should be determined, followed by measurement of plasma triglyceride concentrations. This will allow differentiation of whether the low density lipoproteins (LDL), HDL cholesterol or triglyceride-rich particles such as the small dense beta-very low density lipoproteins (VLDL) are the major cause for concern. Once identified, those individuals with a high lipid risk profile should be treated before, rather than after, experiencing coronary heart disease (CHD).
Similar articles
-
Diabetic dyslipidemia.Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. doi: 10.1016/s0002-9149(98)00848-0. Am J Cardiol. 1998. PMID: 9915665 Review.
-
Role of fibric acid derivatives in the management of risk factors for coronary heart disease.Drugs. 2004;64(19):2177-98. doi: 10.2165/00003495-200464190-00003. Drugs. 2004. PMID: 15456334 Review.
-
The emergence of triglycerides as a significant independent risk factor in coronary artery disease.Eur Heart J. 1998 Oct;19 Suppl M:M8-14. Eur Heart J. 1998. PMID: 9821011
-
The insulin resistance syndrome and postprandial lipid intolerance in smokers.Atherosclerosis. 1997 Feb 28;129(1):79-88. doi: 10.1016/s0021-9150(96)06028-5. Atherosclerosis. 1997. PMID: 9069521
-
Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.Eur Heart J. 1998 Feb;19 Suppl A:A24-30. Eur Heart J. 1998. PMID: 9519339 Review.
Cited by
-
Beyond the cholesterol profile: monitoring therapeutic effectiveness of statin therapy.J Nucl Cardiol. 2001 Jul-Aug;8(4):528-32. doi: 10.1067/mnc.2001.116847. J Nucl Cardiol. 2001. PMID: 11481576 No abstract available.
-
Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study.Cardiovasc Diabetol. 2025 Mar 10;24(1):116. doi: 10.1186/s12933-025-02675-y. Cardiovasc Diabetol. 2025. PMID: 40065297 Free PMC article.
-
Fluorescent lifetime imaging microscopy using Europium complexes improves atherosclerotic plaques discrimination.Int J Cardiovasc Imaging. 2016 Oct;32(10):1595-604. doi: 10.1007/s10554-016-0936-7. Epub 2016 Jul 13. Int J Cardiovasc Imaging. 2016. PMID: 27412686
-
Monitoring effectiveness of medical therapy in 2006.J Nucl Cardiol. 2006 Mar-Apr;13(2):184-90. doi: 10.1007/BF02971242. J Nucl Cardiol. 2006. PMID: 16580954 No abstract available.
-
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.Proc Natl Acad Sci U S A. 2005 Jul 19;102(29):10297-302. doi: 10.1073/pnas.0504379102. Epub 2005 Jul 8. Proc Natl Acad Sci U S A. 2005. PMID: 16006512 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources